Eton Pharmaceutcials, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Eton Pharmaceutcials, Inc. Common Stock (ETON) has a 3-month relative strength percentile of 90 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 77. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.5%, relative volume 2.71×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 90, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ETON is in a stage 2 uptrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 20.2% / 69.0%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
ETON is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $18M notional. Top 3 carry $40M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $18M |
| IWMiShares Russell 2000 ETF | 0.02% | $15M |
| VXFVanguard Extended Market ETF | 0.01% | $6M |
| IWOiShares Russell 2000 Growth ETF | 0.04% | $5M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ETON Jan avg: 12.88% median: 15.01% win: 75% σ: 19.37% n: 4 2022-04-12 → 2026-05-29 | ETON Feb avg: 1.12% median: 1.24% win: 50% σ: 11.08% n: 4 2022-04-12 → 2026-05-29 | ETON Mar avg: 3.86% median: -6.26% win: 50% σ: 29.14% n: 4 2022-04-12 → 2026-05-29 | ETON Apr avg: 1.56% median: -5.71% win: 20% σ: 15.91% n: 5 2022-04-12 → 2026-05-29 | ETON May avg: 7.00% median: 9.09% win: 80% σ: 14.73% n: 5 2022-04-12 → 2026-05-29 | ETON Jun avg: -14.39% median: -12.84% win: 0% σ: 7.31% n: 4 2022-04-12 → 2026-05-29 (current) | ETON Jul avg: -2.03% median: 0.83% win: 50% σ: 12.20% n: 4 2022-04-12 → 2026-05-29 | ETON Aug avg: 23.48% median: 25.01% win: 75% σ: 30.85% n: 4 2022-04-12 → 2026-05-29 | ETON Sep avg: 10.39% median: 9.23% win: 50% σ: 20.42% n: 4 2022-04-12 → 2026-05-29 | ETON Oct avg: 11.67% median: 11.31% win: 75% σ: 25.19% n: 4 2022-04-12 → 2026-05-29 | ETON Nov avg: 12.93% median: 4.05% win: 50% σ: 34.67% n: 4 2022-04-12 → 2026-05-29 | ETON Dec avg: 5.07% median: 1.58% win: 50% σ: 13.28% n: 4 2022-04-12 → 2026-05-29 |